• Skip to primary navigation
  • Skip to main content
ASP logo
Discovering nature's molecular potential
  • Journal
  • News
  • Events
  • About
    • ASP Mission and History
    • Officers & Committees
    • Constitution & Bylaws
    • Diversity Equity and Inclusion Committee
    • ASP Fellows
    • ASP Honorary Members
    • Younger Members Committee
    • ASP Foundation
    • Past Presidents of the ASP
  • Membership
    • Join ASP
    • Membership Renewal
    • ASP Student Chapters
    • Members Only Login
  • Events
    • ASP Annual Meeting
    • Younger Members Symposium
    • ASP Webinars
    • Calendar of Events
  • Publications
    • ASP Newsletter
    • Journal of Natural Products
    • Research
    • Society Archives
  • Resources
    • Employment Opportunities
    • Programs and Research Map
    • Sign up for NP Career Finder
    • Grants and Awards
      • Grant & Award Specific Directions
    • Post a Job
    • Graduate Programs
    • ASP Summer Research Fellowship
    • Undergraduate Summer Internships
    • Links (Organizations, Societies, Associations, & Institutes)
    • Image Gallery
  • Contact
  • Donate Here
You are here: Home / Newsletter / Winter 2020

Winter 2020

ASP Newsletter: Winter 2020, Volume 56, Issue 4

Winter 2020

Discovering Nature’s Molecular Potential

Meet a New ASP Member: Dr. Elizabeth (Betsy) Parkinson

Dr. Elizabeth (Betsy) Parkinson, our featured new member in this issue of the Newsletter, began her appointment as an assistant professor in the Department of Chemistry and the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University in August of 2018. In addition to ASP, Dr. Parkinson is also a member of the American Chemical Society and the Society for Industrial Microbiology and Biotechnology (SIMB). We thank Dr. Parkinson for taking the time to talk with us and are pleased to officially welcome her to ASP.

HOT TOPICS IN PHARMACOGNOSY: The Evolution of Dolastatin 10 Derivatives as Sources of ADC Warheads

Hot Topics Flame SMALL

Though natural product chemists who specialize in marine-sourced agents are usually aware of the contribution of structures based upon dolastatin 10 as warheads in antibody drug conjugates (ADCs), targeted against cancers of varying etiologies, the majority of ASP members may not be aware of the significant contributions made as a result of studies by the Pettit group starting in the middle 1960s.

Investing in Natural Products

After 25 years of working as a scientist in increasingly entrepreneurial environments, including positions at early stage platform and drug discovery/development companies, a late-night chance encounter in 2000 at Raleigh Durham airport with Arthur Pappas, a life science investor, was my introduction into the world of venture capital.

O’Keefe Interviewed for BBC Documentary

Dr. Barry O’Keefe is interviewed for the BBC documentary 'Extinction: The Facts'

On September 2020, the BBC released Extinction: The Facts, a documentary about the sixth mass extinction. It is narrated by Sir David Attenborough, a natural historian known for his work in BBC’s Life series. The 58-minute film shows the effects of biodiversity loss and climate change. Attenborough, together with renowned scientists from different fields, provide a series of shocking facts that make this documentary a compulsory watch for all.

  • Newsletter
    • 2020
      • Fall 2020
        • Opinion: Current Federal Policies Are Injurious to US Science and Natural Products Research
        • ASP President Oberlies Addresses Members
        • Exploring Berry Patches at the Top of the World
        • Full Newsletter
      • Winter 2020
        • HOT TOPICS IN PHARMACOGNOSY: The Evolution of Dolastatin 10 Derivatives as Sources of ADC Warheads
        • Full Newsletter
    • 2021
      • Spring 2021
        • ASP Members Recognized Among Most Influential Scientists
        • Making STEM a Safer Place
        • HOT TOPICS IN PHARMACOGNOSY: Chemistry and CoV-2 Treatments
        • Full Newsletter
      • Summer 2021
        • HOT TOPICS IN PHARMACOGNOSY: So What About the Other Half of Kinase Inhibitor Activities?
        • Taking Action: The Imposter Syndrome and Graduate Minority Students
        • ASP Hosts Virtual Symposium in an Interactive Environment
        • Full Newsletter
      • Fall 2021
        • HOT TOPICS IN PHARMACOGNOSY: Revisions of “Repurposing for CoV-2” and Potential Uses of Cationic Peptide Compounds as Antibiotics and Other Diseases
        • Inaugural ASP Vanguards Virtual Symposium Series a Great Success!
        • ASP President McPhail Addresses Members
        • Full Newsletter
      • Winter 2021
        • Behind the Scenes in Pharmacognosy: Antibacterial Peptides from Ghost Pepper
        • Meet a New ASP Member: Dr. Jie Li
        • Full Newsletter
    • 2022
      • Spring 2022
        • Pharmacognosy Dispatches from the Ukrainian Frontline
        • Successful ASP Summer Research Fellowship Program Continues in 2022
        • Full Newsletter
      • Summer 2022
        • Behind the Scenes in Pharmacognosy: Smoke Taint in American West Coast Wines
        • Full Newsletter
      • Fall 2022 – Full Newsletter
    • Newsletter Archives

NEWSLETTER STAFF

Edward J. Kennelly, PhD

Editor In Chief

Patricia Carver, MA

Copyediting & Proofreading

Nancy Novick

Design & Production

Gordon Cragg, PhD

Mario Figueroa, PhD

Joshua Kellogg, PhD

Michael Mullowney, PhD

Guido Pauli, PhD

Patricia Van Skaik, MA, MLS

Jaclyn Winter, PhD

ASP Newsletter Committee

Contribution deadlines

Spring: Feb. 15; Summer: May 15 Fall: Aug. 15; Winter:Nov. 15

Please send information to

Edward J. Kennelly, PhD Editor In Chief,
ASP Newsletter
Department of Biological Sciences
Lehman College, CUNY
250 Bedford Park Blvd. West Bronx, NY 10468

718-960-1105

asp.newsletter@
lehman.cuny.edu

ISSN 2377-8520 (print) ISSN 2377-8547 (online)

Facebook Twitter LinkedIn Instagram
© 2025 The American Society of Pharmacognosy. All rights reserved.
View our Privacy policy and Cancellation policy
Join The ASP